Prevalence and characterization of Clostridium perfringens toxinotypes among patients with antibiotic-associated diarrhea in Iran.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
24 05 2019
Historique:
received: 13 11 2018
accepted: 14 05 2019
entrez: 26 5 2019
pubmed: 28 5 2019
medline: 21 10 2020
Statut: epublish

Résumé

Clostridium perfringens has emerged as an important cause of antibiotic-associated diarrhea (AAD), particularly in the hospital environment. Here we investigated the prevalence and molecular epidemiology of C. perfringens isolated from 2280 fecal samples from Iranian diarrheal patients suspected of having AAD. Overall, AAD was diagnosed in 13.3% (303/2280) of patients and associated with advanced age (>50 years, P = 0.001). A total of 106 C. perfringens isolates were cultured from AAD (n = 68) and non-AAD (n = 38) groups, with toxinotypes A and F comprising 84% and 16% of isolates, respectively. Notably, 41.2% of type F strains were also cpb2-positive and enterotoxigenic cpe-positive strains were detected in 13.2% of the isolates from AAD patients. Genes associated with the VirR/VirS signal transduction (virR, virS) and accessory gene regulator (agrB, agrD) systems were detected in 56.6% and 67% of the isolates, respectively, and peptides of the quorum-sensing modulator, AgrD were highly conserved across all strains. The high prevalence of C. perfringens in Iranian AAD patients suggests that diagnostic laboratories in this region should consider screening for C. perfringens in cases of suspected AAD, especially if the specimen is negative for other pathogens and/or the patients are aged >50 years.

Identifiants

pubmed: 31127185
doi: 10.1038/s41598-019-44281-5
pii: 10.1038/s41598-019-44281-5
pmc: PMC6534674
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Toxins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7792

Références

Lancet. 1984 Feb 11;1(8372):305-7
pubmed: 6141380
J Clin Microbiol. 1994 Oct;32(10):2533-9
pubmed: 7814493
Res Microbiol. 2015 May;166(4):264-79
pubmed: 25283728
Infect Immun. 2011 Jun;79(6):2451-9
pubmed: 21464088
Microbiol Mol Biol Rev. 2013 Jun;77(2):208-33
pubmed: 23699255
Indian J Med Res. 2005 Jul;122(1):52-6
pubmed: 16106091
PLoS One. 2010 Jun 03;5(6):e10932
pubmed: 20532170
J Bacteriol. 1988 Sep;170(9):4365-72
pubmed: 2457579
Front Microbiol. 2015 Oct 27;6:1174
pubmed: 26579084
J Clin Microbiol. 2006 Aug;44(8):2785-91
pubmed: 16891493
Clin Infect Dis. 2002 Feb 1;34(3):346-53
pubmed: 11774082
Eur J Clin Microbiol Infect Dis. 2001 Sep;20(9):676-7
pubmed: 11714055
Infect Immun. 2012 Sep;80(9):3008-17
pubmed: 22689820
Trends Microbiol. 2016 Jun;24(6):463-476
pubmed: 26897710
Mol Microbiol. 2005 Sep;57(6):1570-81
pubmed: 16135225
J Med Microbiol. 2003 Sep;52(Pt 9):753-757
pubmed: 12909650
Clin Infect Dis. 2008 Nov 1;47(9):e74-8
pubmed: 18808355
Emerg Microbes Infect. 2018 Aug 6;7(1):141
pubmed: 30082713
J Crohns Colitis. 2014 Apr;8(4):276-81
pubmed: 24060617
J Bacteriol. 2015 May;197(10):1807-18
pubmed: 25777675
Infect Immun. 2017 May 23;85(6):
pubmed: 28373356
J Clin Microbiol. 2009 Mar;47(3):807-10
pubmed: 19109478
Open Toxinology J. 2010;2:24-42
pubmed: 24511335
J Hosp Infect. 2006 Jul;63(3):323-9
pubmed: 16650503
Infection. 2005 Oct;33(5-6):340-4
pubmed: 16258864
mBio. 2011 Dec 13;2(6):
pubmed: 22167225
J Clin Pathol. 1992 Jul;45(7):609-11
pubmed: 1517462
Toxins (Basel). 2016 Mar 16;8(3):
pubmed: 26999202
J Clin Pathol. 2001 Oct;54(10):748-51
pubmed: 11577119
Infect Immun. 2006 Sep;74(9):5200-10
pubmed: 16926413
Int J Antimicrob Agents. 2009 Mar;33 Suppl 1:S37-41
pubmed: 19303568
J Med Microbiol. 2002 Oct;51(10):891-894
pubmed: 12435070
Mol Microbiol. 2014 Jan;91(2):221-31
pubmed: 24563915
Infect Immun. 2010 Jul;78(7):3064-72
pubmed: 20457789
Anaerobe. 2018 Oct;53:5-10
pubmed: 29866424
PLoS One. 2009 Jul 14;4(7):e6232
pubmed: 19597556
Mol Microbiol. 2005 May;56(3):747-62
pubmed: 15819629
Res Microbiol. 2015 May;166(4):280-9
pubmed: 25303832
Vet Microbiol. 2009 May 12;136(3-4):411-2
pubmed: 19157726
Anaerobe. 2017 Dec;48:34-36
pubmed: 28655582
Mol Microbiol. 2012 Jan;83(1):179-94
pubmed: 22150719
J Med Microbiol. 1995 Dec;43(6):442-5
pubmed: 7473678
Trends Microbiol. 1999 Mar;7(3):104-10
pubmed: 10203838
Infect Immun. 2007 Apr;75(4):1811-9
pubmed: 17261608
Toxins (Basel). 2016 Jul 05;8(7):
pubmed: 27399773
J Bacteriol. 2009 Jun;191(12):3919-27
pubmed: 19363118
Microb Pathog. 2017 Oct;111:232-237
pubmed: 28867621

Auteurs

Masoumeh Azimirad (M)

Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Fatemeh Gholami (F)

Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Abbas Yadegar (A)

Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. a.yadegar@sbmu.ac.ir.

Daniel R Knight (DR)

School of Veterinary and Life Sciences, Murdoch University, Murdoch, Western Australia, Australia.

Sharareh Shamloei (S)

Department of Water and Wastewater Quality Control Laboratory, Water and Wastewater Company, Tehran, Iran.

Hamid Asadzadeh Aghdaei (HA)

Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Mohammad Reza Zali (MR)

Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH